World's Best Scientists 2026 revealed!
Andrew James Godkin

Andrew James Godkin

D-Index & Metrics

Microbiology

D-Index
50
Citations
9145
World Ranking
4445
National Ranking
396

Andrew James Godkin publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Andrew James Godkin sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 188 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Andrew James Godkin D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew James Godkin sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 50 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Andrew James Godkin is a researcher affiliated with Cardiff University in the United Kingdom. Their research spans multiple fields within medicine and immunology, focusing primarily on infectious diseases, immunology, and oncology. Their work also extends into molecular biology and neurology, reflecting a broad interest in immune system functions and disease mechanisms.

The research topics covered by Andrew James Godkin include:

  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Long-Term Effects of COVID-19
  • Vaccines and Immunoinformatics Approaches

The scientist has published in several notable venues, with frequent contributions to the following journals:

  • Oxford Open Immunology
  • Cell Reports
  • Immunology
  • QJM
  • Journal of Clinical Immunology

Among their recent publications are:

  • "COVID-19 Vaccine Response in People with Multiple Sclerosis", 2021, Annals of Neurology
  • "Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity", 2022, Nature Communications
  • "Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity", 2021, Immunotherapy Advances
  • "The Dual Role of High Endothelial Venules in Cancer Progression versus Immunity", 2020, Trends in Cancer
  • "Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3", 2020, Journal for ImmunoTherapy of Cancer

Frequent collaborators of Andrew James Godkin include:

  • Awen Gallimore
  • Martin Scurr
  • Sarah N. Lauder
  • Lorenzo Capitani
  • Kathryn Smart

The main fields of study of their publications comprise medicine and immunology and microbiology, with a significant focus on infectious diseases and immune system responses. Their work addresses critical aspects of immune cell function, cancer immunotherapy, and long-term effects related to COVID-19, illustrating engagement with both clinical and molecular dimensions of immune research.

Best Publications

  • Induction and Exhaustion of Lymphocytic Choriomeningitis Virus–specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I–Peptide Complexes

    Awen Gallimore;Ann Glithero;Andrew Godkin;Alain C. Tissot

  • In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.

    Robert P. Anderson;Pilar Degano;Andrew J. Godkin;Derek P. Jewell

  • Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).

    Andrew Godkin;Thomas Friede;Miles Davenport;Stefan Stevanovic

  • VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium

    Dmitry V Bagaev;Renske M A Vroomans;Jerome Samir;Jerome Samir;Ulrik Stervbo;Ulrik Stervbo

  • CD4+CD25+FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer

    Sarah L. Clarke;Gareth J. Betts;Andrea Plant;Kate L. Wright

  • Contribution of the MHC region to the familial risk of coeliac disease

    S. Bevan;S. Popat;C. P. Braegger;A. Busch

  • Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.

    Saskia J. A. M. Santegoets;Eveline M. Dijkgraaf;Alessandra Battaglia;Philipp Beckhove

  • Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer

    Gareth James Betts;Emma Jones;Syed Junaid;Tariq El-Shanawany

  • Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology

    Sarah Nicol Lauder;Emma Jones;Kathryn Smart;Anja Constanze Bloom

  • Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness.

    Andrew Godkin;Miles Davenport;Adrian V.S. Hill

  • Naturally Processed HLA Class II Peptides Reveal Highly Conserved Immunogenic Flanking Region Sequence Preferences That Reflect Antigen Processing Rather Than Peptide-MHC Interactions

    Andrew J. Godkin;Katherine J. Smith;Anthony Willis;Maria V. Tejada-Simon

  • Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers.

    Anna Lissina;Kristin Ingrid Ladell;Ania Skowera;Ania Skowera;Mathew Clement

  • Evolution of Epitope-Specific Memory CD4+ T Cells After Clearance of Hepatitis C Virus

    Andrew James Godkin;Andrew James Godkin;Howard C. Thomas;Peter J. Openshaw

  • The pathogenesis of celiac disease

    Andrew James Godkin;Derek Jewell

  • Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer

    Martin J Scurr;Tom Pembroke;Anja Bloom;David J Roberts

  • More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers

    Garry Michael Dolton;Katie Tungatt;Angharad Lloyd;Valentina Bianchi

  • Regulatory T cells and tumour immunity – observations in mice and men

    Awen Myfanwy Gallimore;Andrew James Godkin

  • Highly prevalent colorectal cancer-infiltrating LAP⁺ Foxp3⁻ T cells exhibit more potent immunosuppressive activity than Foxp3⁺ regulatory T cells.

    Martin John Scurr;Kristin Ingrid Ladell;Matthieu Besneux;Adam Christian

  • COVID-19 Vaccine Response in People with Multiple Sclerosis.

    Emma C Tallantyre;Emma C Tallantyre;Nicola Vickaryous;Valerie Anderson;Aliye Nazli Asardag

  • Analysis of the T-Cell Receptor Repertoires of Tumor-Infiltrating Conventional and Regulatory T Cells Reveals No Evidence for Conversion in Carcinogen-Induced Tumors

    James Philip Hindley;Cristina Ferreira;Emma Jones;Sarah Nicol Lauder

Frequent Co-Authors

Awen Gallimore
Awen Gallimore Cardiff University
Andrew K. Sewell
Andrew K. Sewell Cardiff University
Kristin Ladell
Kristin Ladell Cardiff University
David Price
David Price University of Aberdeen
Derek P. Jewell
Derek P. Jewell University of Oxford
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
John J. Miles
John J. Miles James Cook University
Miles P. Davenport
Miles P. Davenport University of New South Wales
Howard C. Thomas
Howard C. Thomas Imperial College London
Edward Chung Yern Wang
Edward Chung Yern Wang Cardiff University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a diverse range of career paths, including some that intersect with healthcare and medical technology. Beyond traditional laboratory roles, many graduates explore advanced certifications or degrees to expand their expertise.

For those interested in combining microbiology with patient care, becoming a functional medicine nurse practitioner can be a rewarding option. This role emphasizes holistic health, requiring both clinical and scientific knowledge.

In addition, the healthcare industry offers opportunities in administrative and coding fields. A cpc medical coding salary can be attractive for those skilled in medical terminology and data accuracy.

For microbiology graduates interested in health data management, exploring career options in health information management is beneficial. Understanding the health information management salary entry-level can help evaluate the potential financial rewards in this field.

Finally, pursuing an accredited online health information management degree cahiim offers a flexible pathway to gaining credentials recognized nationally, making graduates highly competitive in healthcare administration and data management.

Best Scientists Citing Andrew James Godkin

Trending Scientists

Recently Published Articles